Venture Partner at Catalio Capital Management
View Live Interactive Profile →Catalio Capital Management lists Vijay K. Kuchroo as a Venture Partner. The firm's profile page gives the current affiliation as Director of The Gene Lay Institute of Immunology and Inflammation of Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School; Samuel L. Wasserstrom Professor of Neurology, Harvard Medical School. His stated honours include the AAI Thermo Fisher Meritorious Career Award (2025), the AAI Distinguished Fellow Award (2021) and the Dystel Prize for MS Research (2021). Catalio's page lists him as a founder of Bicara Pharmaceuticals, POINT Therapeutics, Tempero, CoStim, Potenza, Tizona, Celsius and Larkspur Biosciences, and names board positions at Biocon, Syngene International, Bicara Pharmaceuticals and Zumutor; these were not confirmed against issuer filings and are therefore not recorded as board seats.